Next Gen Diagnostics CEO Paul A. Rhodes Announces Formation of Subsidiary NGD Israel, Ltd.

PRESS RELEASE
Written By Casey-Drew Williams

Next Gen Diagnostics announced today the formation of its subsidiary NGD Israel, Ltd., to offer low-cost pathogen sequencing, transmission detection, and sequence-based infectious disease diagnostics to Israel. NGD’s pathogen sequencing lab will be centrally located to facilitate providing rapid pathogen sequencing service to customers across Israel. NGD will offer a complete turn-key service including extraction, library preparation, sequencing, and fully validated bioinformatic analysis, at unprecedentedly low cost.

Casey-Drew Williams
Previous

NGD CEO Paul Rhodes Announces Appointment of Brigitte Frankel to its Advisory Board
Next

Next Gen Diagnostics Announces Vanderbilt Professor and Leader in Antibiotic Susceptibility Testing Dr. Romney Humphries Has Joined Next Gen Diagnostics Scientific Advisory Board